Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,507 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis for the primary predictive factor for the incidence of esophageal injury after ablation of atrial fibrillation.
Ito M, Yamabe H, Koyama J, Kanazawa H, Kaneko S, Kanemaru Y, Kiyama T, Arima Y, Takashio S, Yamamoto E, Izumiya Y, Kojima S, Kaikita K, Shono T, Utsunomiya D, Sasaki Y, Yamashita Y, Tsujita K. Ito M, et al. Among authors: yamamoto e. J Cardiol. 2018 Dec;72(6):480-487. doi: 10.1016/j.jjcc.2018.05.009. Epub 2018 Jun 21. J Cardiol. 2018. PMID: 29935765 Free article.
Pentraxin 3 is a new inflammatory marker correlated with left ventricular diastolic dysfunction and heart failure with normal ejection fraction.
Matsubara J, Sugiyama S, Nozaki T, Sugamura K, Konishi M, Ohba K, Matsuzawa Y, Akiyama E, Yamamoto E, Sakamoto K, Nagayoshi Y, Kaikita K, Sumida H, Kim-Mitsuyama S, Ogawa H. Matsubara J, et al. Among authors: yamamoto e. J Am Coll Cardiol. 2011 Feb 15;57(7):861-9. doi: 10.1016/j.jacc.2010.10.018. J Am Coll Cardiol. 2011. PMID: 21310324 Free article.
Microvascular coronary artery spasm presents distinctive clinical features with endothelial dysfunction as nonobstructive coronary artery disease.
Ohba K, Sugiyama S, Sumida H, Nozaki T, Matsubara J, Matsuzawa Y, Konishi M, Akiyama E, Kurokawa H, Maeda H, Sugamura K, Nagayoshi Y, Morihisa K, Sakamoto K, Tsujita K, Yamamoto E, Yamamuro M, Kojima S, Kaikita K, Tayama S, Hokimoto S, Matsui K, Sakamoto T, Ogawa H. Ohba K, et al. Among authors: yamamoto e. J Am Heart Assoc. 2012 Oct;1(5):e002485. doi: 10.1161/JAHA.112.002485. Epub 2012 Oct 25. J Am Heart Assoc. 2012. PMID: 23316292 Free PMC article. Clinical Trial.
Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes.
Matsubara J, Sugiyama S, Akiyama E, Iwashita S, Kurokawa H, Ohba K, Maeda H, Fujisue K, Yamamoto E, Kaikita K, Hokimoto S, Jinnouchi H, Ogawa H. Matsubara J, et al. Among authors: yamamoto e. Circ J. 2013;77(5):1337-44. doi: 10.1253/circj.cj-12-1168. Epub 2013 Feb 2. Circ J. 2013. PMID: 23386232 Free article.
Coronary microvascular dysfunction and diastolic load correlate with cardiac troponin T release measured by a highly sensitive assay in patients with nonischemic heart failure.
Takashio S, Yamamuro M, Izumiya Y, Sugiyama S, Kojima S, Yamamoto E, Tsujita K, Tanaka T, Tayama S, Kaikita K, Hokimoto S, Ogawa H. Takashio S, et al. Among authors: yamamoto e. J Am Coll Cardiol. 2013 Aug 13;62(7):632-40. doi: 10.1016/j.jacc.2013.03.065. Epub 2013 May 1. J Am Coll Cardiol. 2013. PMID: 23644085 Free article.
Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction.
Izumiya Y, Hanatani S, Kimura Y, Takashio S, Yamamoto E, Kusaka H, Tokitsu T, Rokutanda T, Araki S, Tsujita K, Tanaka T, Yamamuro M, Kojima S, Tayama S, Kaikita K, Hokimoto S, Ogawa H. Izumiya Y, et al. Among authors: yamamoto e. Can J Cardiol. 2014 Mar;30(3):338-44. doi: 10.1016/j.cjca.2013.12.010. Epub 2013 Dec 18. Can J Cardiol. 2014. PMID: 24484911
1,507 results